Methods Of Determining Risk Of Adverse Outcomes In Acute Myeloid Leukemia


Ontology type: sgo:Patent     


Patent Info

DATE

2012-06-14T00:00

AUTHORS

LEY, TIMOTHY J. , WILSON. RICHARD K. , MARDIS, ELAINE K. , DING, LI , DIPERSIO. JOHN K.

ABSTRACT

Disclosed are methods of determining risk of adverse outcome in a subject diagnosed with acute myeloid leukemia or myelodysplastic syndrome syndrome. The methods comprise providing a sample comprising bone marrow cells and/or peripheral blood from a subject diagnosed with acute myeloid leukemia or myelodysplastic syndrome syndrome, sequencing at least one exon of DNMT3A comprised by the sample, and identifying mutations, if any, in the DNMT3A gene. The presence of one or more mutations in DNMT3A can indicate that the subject is at high risk for an adverse outcome. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3048", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "LEY, TIMOTHY J.", 
        "type": "Person"
      }, 
      {
        "name": "WILSON. RICHARD K.", 
        "type": "Person"
      }, 
      {
        "name": "MARDIS, ELAINE K.", 
        "type": "Person"
      }, 
      {
        "name": "DING, LI", 
        "type": "Person"
      }, 
      {
        "name": "DIPERSIO. JOHN K.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/onc.2010.117", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002918569", 
          "https://doi.org/10.1038/onc.2010.117"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m205312200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008670524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2011.051581", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012143413"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa031046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029492007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature07485", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034796960", 
          "https://doi.org/10.1038/nature07485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/nar/27.11.2291", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050251136"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-06-14T00:00", 
    "description": "

Disclosed are methods of determining risk of adverse outcome in a subject diagnosed with acute myeloid leukemia or myelodysplastic syndrome syndrome. The methods comprise providing a sample comprising bone marrow cells and/or peripheral blood from a subject diagnosed with acute myeloid leukemia or myelodysplastic syndrome syndrome, sequencing at least one exon of DNMT3A comprised by the sample, and identifying mutations, if any, in the DNMT3A gene. The presence of one or more mutations in DNMT3A can indicate that the subject is at high risk for an adverse outcome.

", "id": "sg:patent.WO-2012078288-A2", "keywords": [ "determining", "acute myeloid leukemia", "method", "risk", "adverse outcome", "myelodysplastic syndrome", "sample", "bone marrow cell", "peripheral blood", "sequencing", "exon", "Dnmt3a", "mutation", "gene", "high risk" ], "name": "METHODS OF DETERMINING RISK OF ADVERSE OUTCOMES IN ACUTE MYELOID LEUKEMIA", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.34477.33", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/WO-2012078288-A2" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:09", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_00353.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.WO-2012078288-A2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.WO-2012078288-A2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.WO-2012078288-A2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.WO-2012078288-A2'


 

This table displays all metadata directly associated to this object as RDF triples.

73 TRIPLES      15 PREDICATES      35 URIs      23 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.WO-2012078288-A2 schema:about anzsrc-for:3048
2 schema:author Nde21d5d26bdc413291dd823bdcc1bd78
3 schema:citation sg:pub.10.1038/nature07485
4 sg:pub.10.1038/onc.2010.117
5 https://doi.org/10.1056/nejmoa031046
6 https://doi.org/10.1074/jbc.m205312200
7 https://doi.org/10.1093/nar/27.11.2291
8 https://doi.org/10.3324/haematol.2011.051581
9 schema:datePublished 2012-06-14T00:00
10 schema:description <p>Disclosed are methods of determining risk of adverse outcome in a subject diagnosed with acute myeloid leukemia or myelodysplastic syndrome syndrome. The methods comprise providing a sample comprising bone marrow cells and/or peripheral blood from a subject diagnosed with acute myeloid leukemia or myelodysplastic syndrome syndrome, sequencing at least one exon of <i>DNMT3A</i> comprised by the sample, and identifying mutations, if any, in the <i>DNMT3A</i> gene. The presence of one or more mutations in <i>DNMT3A </i>can indicate that the subject is at high risk for an adverse outcome.</p>
11 schema:keywords Dnmt3a
12 acute myeloid leukemia
13 adverse outcome
14 bone marrow cell
15 determining
16 exon
17 gene
18 high risk
19 method
20 mutation
21 myelodysplastic syndrome
22 peripheral blood
23 risk
24 sample
25 sequencing
26 schema:name METHODS OF DETERMINING RISK OF ADVERSE OUTCOMES IN ACUTE MYELOID LEUKEMIA
27 schema:recipient https://www.grid.ac/institutes/grid.34477.33
28 schema:sameAs https://app.dimensions.ai/details/patent/WO-2012078288-A2
29 schema:sdDatePublished 2019-04-18T10:09
30 schema:sdLicense https://scigraph.springernature.com/explorer/license/
31 schema:sdPublisher N51bcbd5d497f4aad8914fbed95b3dad2
32 sgo:license sg:explorer/license/
33 sgo:sdDataset patents
34 rdf:type sgo:Patent
35 N0fc64f4429f348ab8bf89a04c5e19a0d schema:name DIPERSIO. JOHN K.
36 rdf:type schema:Person
37 N10e0964ac77d4c0e8059d39675f1c9d6 rdf:first N0fc64f4429f348ab8bf89a04c5e19a0d
38 rdf:rest rdf:nil
39 N1d64524837524e2ba33fc2c84438c2f8 schema:name WILSON. RICHARD K.
40 rdf:type schema:Person
41 N23498236f3c742d5a3bb3f89f52a3a5b rdf:first N35ec4a5b6dfa4112964cda7ff39e910a
42 rdf:rest N7b13d64a8c424a338288778831f4cf15
43 N35ec4a5b6dfa4112964cda7ff39e910a schema:name MARDIS, ELAINE K.
44 rdf:type schema:Person
45 N43a707a209fd4585a1cf610bb6d1b143 rdf:first N1d64524837524e2ba33fc2c84438c2f8
46 rdf:rest N23498236f3c742d5a3bb3f89f52a3a5b
47 N51bcbd5d497f4aad8914fbed95b3dad2 schema:name Springer Nature - SN SciGraph project
48 rdf:type schema:Organization
49 N7b13d64a8c424a338288778831f4cf15 rdf:first Nf4be4c6fb05d4db783af3dbb322f5aef
50 rdf:rest N10e0964ac77d4c0e8059d39675f1c9d6
51 Nde21d5d26bdc413291dd823bdcc1bd78 rdf:first Nef3a1dbfa7de45ceb5fcf10456139f89
52 rdf:rest N43a707a209fd4585a1cf610bb6d1b143
53 Nef3a1dbfa7de45ceb5fcf10456139f89 schema:name LEY, TIMOTHY J.
54 rdf:type schema:Person
55 Nf4be4c6fb05d4db783af3dbb322f5aef schema:name DING, LI
56 rdf:type schema:Person
57 anzsrc-for:3048 schema:inDefinedTermSet anzsrc-for:
58 rdf:type schema:DefinedTerm
59 sg:pub.10.1038/nature07485 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034796960
60 https://doi.org/10.1038/nature07485
61 rdf:type schema:CreativeWork
62 sg:pub.10.1038/onc.2010.117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002918569
63 https://doi.org/10.1038/onc.2010.117
64 rdf:type schema:CreativeWork
65 https://doi.org/10.1056/nejmoa031046 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029492007
66 rdf:type schema:CreativeWork
67 https://doi.org/10.1074/jbc.m205312200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008670524
68 rdf:type schema:CreativeWork
69 https://doi.org/10.1093/nar/27.11.2291 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050251136
70 rdf:type schema:CreativeWork
71 https://doi.org/10.3324/haematol.2011.051581 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012143413
72 rdf:type schema:CreativeWork
73 https://www.grid.ac/institutes/grid.34477.33 schema:Organization
 




Preview window. Press ESC to close (or click here)


...